Shree Ganesh Remedies balance sheet

As of Mar 2026

Total assets: ₹208cr+8.2% on Mar 2025
Shareholders' equity: ₹163cr+12.3% on Mar 2025
Total debt: ₹30.7cr−19.8% on Mar 2025
Cash and investments: ₹25.8cr−8.3% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Non-current assets
	105	95.0	80.5
	12.4	8.3	16.6
	0.0	0.0	0.1
	0.5	0.4	0.3
	0.2	0.2	0.2
	—	—	1.2
	—	—	1.3
	1.8	9.0	2.0
	122	114	101
Current assets
	24.0	22.0	25.0
	12.5	18.3	4.7
	32.6	22.3	20.3
	13.4	9.9	15.8
	0.1	0.1	0.4
	0.2	0.6	0.0
	58.6	51.1	41.2
	3.2	4.1	3.9
	85.8	77.5	70.1
	208	192	171
Equity
	12.8	12.8	12.8
	150	132	109
	163	145	—
	163	145	122
Liabilities
	21.2	29.5	29.1
	21.2	29.5	29.1
	0.6	0.5	0.3
	1.1	0.5	0.6
	23.0	30.6	30.2
	9.4	8.8	7.2
	9.4	6.0	8.2
	2.0	1.2	1.8
	20.9	16.0	—
	0.0	0.0	0.0
	0.6	0.0	1.5
	0.2	0.2	0.0
	21.7	16.2	—
	44.7	46.8	—
	208	192	171

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SGRL₹658.00

Shree Ganesh Remedies Limited

· Pharma & Health

₹ CrorePeersBPLPHARMA JENBURPH KPL MAKERSL NOVARTIND PARNAXLAB SHUKRAPHAR SUNLOCMcap ₹845 Cr

View

In ₹ Crore except Per Share As of	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	80.5	95.0	104.6
+ Capital Work-in-Progress	16.6	8.3	12.4
+ Other Intangibles	0.1	0.0	0.0
+ Intangibles under Development	0.3	0.4	0.5
+ Non-current Investments	0.2	0.2	0.2
+ Other Non-current Financial Assets	1.2	—	—
Non-current Financial Assets	1.3	—	—
+ Other Non-current Assets	2.0	9.0	1.8
Total Non-current Assets	100.8	114.4	121.9
Current Assets
+ Inventories	25.0	22.0	24.0
+ Current Investments	4.7	18.3	12.5
+ Trade Receivables	20.3	22.3	32.6
+ Cash & Cash Equivalents	15.8	9.9	13.4
+ Other Bank Balances	0.4	0.1	0.1
+ Other Current Financial Assets	0.0	0.6	0.2
Current Financial Assets	41.2	51.1	58.6
+ Other Current Assets	3.9	4.1	3.2
Total Current Assets	70.1	77.5	85.8
Total Assets	170.9	192.0	207.7
Equity
+ Equity Share Capital	12.8	12.8	12.8
+ Other Equity / Reserves	109.3	132.4	150.2
Equity — Owners of Parent	—	145.2	163.0
Total Equity	122.1	145.2	163.0
Liabilities
+ Borrowings — Non-current	29.1	29.5	21.2
Non-current Financial Liabilities	29.1	29.5	21.2
+ Provisions — Non-current	0.3	0.5	0.6
+ Deferred Tax Liabilities	0.6	0.5	1.1
Non-current Liabilities	30.2	30.6	23.0
+ Borrowings — Current	7.2	8.8	9.4
+ Trade Payables	8.2	6.0	9.4
+ Other Current Financial Liab	1.8	1.2	2.0
Current Financial Liabilities	—	16.0	20.9
+ Provisions — Current	0.0	0.0	0.0
+ Current Tax Liabilities	1.5	0.0	0.6
+ Other Current Liabilities	0.0	0.2	0.2
Current Liabilities	—	16.2	21.7
Total Liabilities	—	46.8	44.7
Total Equity & Liabilities	170.9	192.0	207.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.